The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Andrew Griffiths, Director of the Biochemistry Laboratory at ESPCI ParisTech.
Andrew Griffiths, born in 1964 in Hathersage, U.K., is Professor of Biochemistry at the ESPCI ParisTech, Paris since September 2012. In 2013, he co-founded HiFiBiO, a start-up company developing high-throughput solutions based on single cell technologies for drug discovery.
Andrew Griffiths received a B.Sc. in Biochemistry (First Class) from the University of Sheffield in 1985 and a Ph.D. from the University of Leicester in 1988. He then joined Greg Winter at the MRC Laboratory of Molecular Biology (LMB), Cambridge. There he started developing phage-display
for the selection of human antibodies for therapy, first as a Post Doc. (1989-1990) and later as a Cancer Research Campaign Fellow (1991-1995). This led to the creation of the Cambridge Antibody Technology and Domantis and to the drugs Humira® and Benlysta®.
From 1995 to 2005, while working as a Senior Scientist at the LMB, with Dr. Dan Tawfik, Andrew Griffiths developed a novel system for high-throughput screening and directed evolution based on in vitro compartmentalisation (IVC) of reactions in aqueous microdroplets in water-in-oil emulsions.
In 2004, based on the intellectual property (IP) associated with this work, he co-founded RainDance Technologies, who market droplet-based microfluidic systems for targeted resequencing and digital PCR. He holds an ERC Advanced Grant and is also coordinator and deputy coordinator, respectively, of two Investissement d’Avenir projects: DigiDiag and Medalis.
HONORS AND AWARDS
In October 2005, he received a Chaire d’Excellence from the French Research Ministry, which enabled him to move his team to the Institut de Science et d’Ingénierie Supramoléculaires (ISIS) in Strasbourg. There he developed droplet-based microfluidic systems for directed evolution of enzymes,
high-throughput screening for drug discovery and diagnostic applications.
Updated on 16/06/2014
Welcome to Pasteur Museum
The Pasteur Museum is located at the Institut Pasteur, situated at:
25 rue du Docteur Roux
75015 Paris, France